Paion (DE: PA8)

Last close As at 22/05/2024

2.46

0.00 (0.00%)

Market capitalisation

163m

Edison Investment Research is terminating coverage on Paion. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Paion — GA data enable an application for surgical use

Healthcare | QuickView

Paion — Commercialisation of remimazolam underway

Healthcare | research

Paion — Remimazolam: Three major approvals

Healthcare | Update

Paion — ByFavo – poised for autumn US launch

Financials

Edison Investment Research is terminating coverage on Paion. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Update

Healthcare

Paion — Progressing towards filings in US and Japan

Update

Healthcare

Paion — Remimazolam set for commercialisation in 2019

Update

Healthcare

Paion — Positive data in bronchoscopy Phase III

Update

Healthcare

Paion — On track for two filings by mid-2018

Update

Healthcare

Paion — On track to file in US and Japan by mid-2018

research

Healthcare

Paion — Positive data in high-risk patients

Outlook

Healthcare

Paion — Update 21 November 2016

Update

Healthcare

Paion — Update 5 July 2016

Update

Healthcare

Paion — Update 17 May 2016

Update

Healthcare

Paion — Update 16 February 2016

Update

Healthcare

Paion — Update 9 February 2016

Update

Healthcare

Paion — Update 17 November 2015